Shanghai OuDaXin New Material Technology Center
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shanghai OuDaXin New Material Technology Center between 11 Aug 2025 and 6 Dec 2025. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Shanghai OuDaXin New Material Technology Center
Retatrutide
Tested 4 Samples
Last test 6 Dec 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Shanghai OuDaXin New Material Technology Center
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
6 Dec 2025
First
11 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 6 Dec 2025 | View | 30mg | ⚠️ Sample does not contain Retatrutide | (no batch ID) | White Label / Gold Crimp / Clear Cap | Lab E | Public | |||
| 25 Nov 2025 | View | 30mg | ⚠️ Sample does not contain Retatrutide | (no batch ID) | No Label / Gold Crimp / Clear Cap | Lab E | Public | |||
| 25 Nov 2025 | View | 10mg | ⚠️ Sample does not contain Retatrutide | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |||
| 11 Aug 2025 | View | 20mg | 19.9mg | -0.5% | 99.92% | P250422 | Blue Label / Silver Crimp / Violet Cap | Lab E | Public | |